GlassScriptPhysician profile
Paul T Shaffer
NPI 1528529187
$5,018.16
in general payments reported to CMS, 2019-2025
10 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2021: $1,332 · 2022: $1,090 · 2023: $1,638 · 2024: $502 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,757 · Travel and Lodging: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,756.97 |
| Travel and Lodging | $709.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,984.05 | 2022-2025 | Prostep, Prophecy, N/A |
| Medwest Associates | $1,210.56 | 2021 | |
| Kerecis Limited | $288.82 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bone Support INC. | $128.84 | 2019 | |
| Depuy Synthes Sales INC. | $121.71 | 2021 | |
| Horizon Therapeutics Plc | $115.90 | 2022 | |
| Nevro Corp. | $76.83 | 2022 | |
| Bioventus LLC | $47.09 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Grt US Holding, INC. | $28.52 | 2022 | |
| Acumed LLC | $15.84 | 2023 | Acumed, Innate Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.